Action Date Anticipated News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Action Date Anticipated. Real-time updates on events, politics, business and more.

ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results

May 15, 2023

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® for the Treatment of Allergic Reactions , Including Anaphylaxis New Drug and Marketing Authorization... | May 15, 2023

United States Richard Lowenthal Justin Chakma Eric Karas Advisory Committee Drug Administration

Source: marketscreener.com

ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

March 23, 2023

New Drug Application and Marketing Authorization Application for neffy® Currently Under Review with the FDA and EMA; FDA PDUFA Target Action Date Anticipated in Mid-2023 Strong Financial... | March 23, 2023

United States Justin Chakma Richard Lowenthal American Academy Of Allergy European Medicines Agency Pharmaceuticals Inc

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Action Date Anticipated News Today

ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results

ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

Explore More Categories